BridgePharm company to provide services of high quality on carrying out all phases of clinical trials (I-IV) of medicines on favorable terms.
Successful cooperation with medical institutions and investigators with significant experience in different nosology groups allows to quickly select the most suitable clinical sites for the most complex research activities.
Development of Preclinical study plan
Acute and subacute (subchronic) toxicity, chronic toxicity, local irritant effect
The specific types of toxicity:
Mutagenicity, reproductive toxicity, carcinogenic effects, allergenic effects, immunotoxic effects
Specific pharmacological activity in vivo, in vitro.
PD/PK studies (specific pharmacology activity)
Acute and subacute (subchronic) toxicity, chronic toxicity, local irritant effect in comparison with the registered reference product.
In vitro studies (in cell culture / receptor binding studies), chronic toxicity, local irritant effect, immunotoxic effects, PD/PK studies in comparison with the registered reference product.
Study design development
· Test product / reference product / control (placebo, active control)
· Amount of groups and animals within a group
· Administration of the product
· Types of the studies
Selection of the research sites based on the study design
· Site facilities audit
· Study audit
· Ensuring GLP compliance
Validation of preclinical study reports
· Review of the study report and ensuring of compliance with local and international requirements
· Development of preclinical program meeting the local registration requirements
Home Page Registration Data management Clinical trials
LLC «BRIDGE PHARM»
119571, Moscow, Str. 26 Bakinskikh Kommisarov, 5, office 3
INN 7708799217 KPP 770801001
You make us better.
our manager will contact You.
Request has been sent.
Our manager will contact You